>>
Industry>>
Healthcare>>
Atessia Takes a Strategic Leap...Atessia, Life Science Advisors, a key player in regulatory affairs and pharmaceutical consulting, announces the integration of AnticipSanté, a leading expert in health and pharmaceutical vigilance, into Atessia & Co.'s LifeSciences constellation.
Effective from January 1, 2025, this integration marks a strategic milestone for Atessia, further establishing its position as a vital partner for supporting healthcare stakeholders with regulatory and operational challenges related to vigilance in France and Europe.
Founded in 2017 by Dr. Géraldine Baudot-Visser, Atessia, Life Science Advisors has become a trusted name in regulatory and pharmaceutical consulting, as well as medical devices. The company supports the health industry through every strategic phase of their projects, from design, compliance, registration, to the commercialization of healthcare products and their ongoing compliance.
Atessia focuses on excellence and customization to help pharmaceutical industry players, whether small or large, navigate complex and ever-evolving regulatory requirements. Leveraging its expertise, Atessia facilitates market access through tailored solutions, including support for early access initiatives and managing pharmaceutical responsibilities related to the operator status under the French Public Health Code. Atessia is committed to transforming regulatory challenges into tangible opportunities for its clients-partners.
Founded in 2004 by Dr. Nathalie Casaburo, AnticipSanté earned its reputation as a specialist in health and pharmaceutical vigilance. For nearly two decades, the company has supported the pharmaceutical, cosmetics, and nutrition industries with essential services such as the establishment of pharmacovigilance systems, quality auditing, regulatory document drafting, preparing for internal and external audits, and providing support during pharmacovigilance inspections. AnticipSanté also brings its expertise in signal management, PSUR creation, risk management plans, and medico-legal issues.
AnticipSanté becomes
“ AnticipSanté by Atessia ”
"This union marks the meeting of two experts driven by a shared vision of excellence in service to healthcare stakeholders."
The acquisition of AnticipSanté embodies our ambition to continuously push further to meet the growing needs of the healthcare industry. By joining forces, we are forming a strong and agile alliance to address the sector’s challenges.
Dr. Géraldine BAUDOT-VISSER
Since the founding of AnticipSanté, my priority has always been to offer close, excellence-based support built on trust. Today, as a sister company of Atessia & Amarylys, I am confident that AnticipSanté's partners will not only benefit from the continuity of this commitment but also from an expanded expertise and even more comprehensive support in overcoming their regulatory challenges.
Dr. Nathalie CASABURO
Thanks to this integration, " AnticipSanté by Atessia " is now able to offer a comprehensive 360° solution combining expertise and know-how to stay by your side in the long term:
Implementation and management of vigilance systems for marketed and clinical trial products
Operational and strategic support for dedicated teams
Regulatory compliance and risk management related to vigilance